Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study-Reference-Cited by-同舟云学术

Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

Published:2015-11-04 Issue:1 Volume:13 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Reinders Marlies E. J.,Dreyer Geertje J.,Bank Jonna R.,Roelofs Helene,Heidt Sebastiaan,Roelen Dave L.,Zandvliet Maarten L.,Huurman Volkert A. L.,Fibbe Wim E.,van Kooten Cees,Claas Frans H. J.,Rabelink Ton J.,de Fijter Johan W.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-015-0700-0

Reference56 articles.

1. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11(3):450–62.

2. Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J transplant off J Am Soc Transplant Am Soc Transplant Surg. 2009;9(11):2520–31. doi: 10.1111/j.1600-6143.2009.02799.x .

3. Gaston RS, Cecka JM, Kasiske BL, Fieberg AM, Leduc R, Cosio FC, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation. 2010;90(1):68–74. doi: 10.1097/TP.0b013e3181e065de .

4. Halloran PF, Reeve JP, Pereira AB, Hidalgo LG, Famulski KS. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies. Kidney Int. 2014;85(2):258–64. doi: 10.1038/ki.2013.300 .

5. Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation. 2009;87(10):1505–13. doi: 10.1097/TP.0b013e3181a44206 .

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nasopharyngeal carriage and antibiotic susceptibility patterns of Sstreptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus among urban Ugandan children post-PCV10 introduction: a cross-sectional study;African Health Sciences;2023-12-27

2. Use of Stem Cells for the Treatment of Musculoskeletal Injuries in Horses;Veterinary Clinics of North America: Equine Practice;2023-12

3. Cell-free DNA measurement of three genomes after allogeneic MSC therapy in kidney transplant recipients indicates early cell death of infused MSC;Frontiers in Immunology;2023-11-02

4. Mesenchymal Stem/Stromal Cells in Progressive Fibrogenic Involvement and Anti-Fibrosis Therapeutic Properties;Frontiers in Cell and Developmental Biology;2022-06-01

5. Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis;Cytotherapy;2022-06